成人丘脑胶质瘤的手术治疗与生存结局:单中心8年经验
该单中心回顾性研究连续纳入102例新诊断成人丘脑胶质瘤患者,中位年龄41岁,60.8%为胶质母细胞瘤,45.1%实现GTR/NTR,中位OS为13.6个月。Cox回归显示症状持续时间较长、术前KPS较好、最大程度切除及较低肿瘤分级为独立预后因素;GTR/NTR联合放化疗较其他方案显示显著OS优势。
要点
- 最大程度手术切除可为成人丘脑胶质瘤带来生存获益。
- GTR/NTR联合放化疗较其他治疗方案可能带来更优OS获益。
- 症状持续时间较长、术前KPS较好、最大程度切除及较低分级与更长OS独立相关。
核心结论
- 最大程度手术切除可带来生存获益,GTR/NTR联合放化疗可能较其他方案带来更优OS获益。
研究设计与样本
- 单中心回顾性分析,连续纳入新诊断且接受手术切除的成人丘脑胶质瘤患者共102例,中位年龄41岁(范围18-68岁),男性56例(54.9%)。
主要发现
- 62例(60.8%)为胶质母细胞瘤,46例(45.1%)实现GTR/NTR,50例(49.0%)为STR,6例(5.9%)为PR。
- 术后71.6%的患者接受辅助治疗,中位OS为13.6个月(范围1周-75个月)。
- Cox回归显示症状持续时间较长(p=0.024)、术前KPS较好(p=0.045)、最大程度切除(p=0.013)及较低肿瘤分级(p=0.002)为独立预后因素,与更长OS相关。
- 生存分析显示GTR/NTR联合放化疗较其他治疗方案具有显著OS优势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Given the rarity in the population with adult thalamic gliomas (ATGs), comprehensive characteristics, treatments and survival outcome are not well characterized. This study was conducted to investigate the comprehensive characteristic and treatment of ATGs and identify the prognostic factors associated with overall survival (OS). METHODS: A retrospective analysis of newly diagnosed ATGs who underwent surgical resection consecutively was conducted. Survival analysis of OS was performed by Kaplan-Meier analysis. Cox proportional hazard model was used to investigate the possible prognostic factors associated with OS. RESULTS: A total of 102 patients with ATG were enrolled in this study. The median age was 41 years (range 18-68 years). There were 56 (54.9%) males. Sixty-two patients (60.8%) had glioblastoma (GBM). Among these patients, 46 patients (45.1%) had GTR/NTR, 50 patients (49.0%) had STR and 6 patients (5.9%) had PR. Postoperatively, 71.6% of these patients received adjuvant therapy. The median OS was 13.6 months (range 1 week-75 months). COX regression analysis revealed that ATG patients with longer duration of symptoms (p = 0.024), better pre-KPS (p = 0.045), maximal resection (p = 0.013), or lower tumor grade (p = 0.002) had longer OS, and these predictors are considered as independent prognostic factors. Survival analysis showed that ATGs with GTR/NTR plus chemoradiotherapy had significant OS advantage compared with other treatment regimens. CONCLUSIONS: This study comprehensively summarized the characteristics, treatments and survival outcomes of ATGs in the largest sample size. Maximal surgical resection can bring survival benefit. Combined-modality therapy regimen of GTR/NTR plus chemoradiotherapy may be better beneficial for OS than other regimens.
引用
- Niu X, Wang T, Zhou X, et al. Surgical treatment and survival outcome of patients with adult thalamic glioma: a single institution experience of 8 years. J Neurooncol. 2020. PMID: 32157551. doi:10.1007/s11060-020-03430-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。